Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain.
Department of Sport Sciences, Sports Research Centre, Miguel Hernández University of Elche, 03202 Elche, Spain.
Int J Environ Res Public Health. 2023 Feb 4;20(4):2764. doi: 10.3390/ijerph20042764.
The verification phase (VP) has been proposed as an alternative to the traditional criteria used for the determination of the maximum oxygen uptake (VO max) in several populations. Nonetheless, its validity in patients with heart failure with reduced ejection fraction (HFrEF) remains unclear. Therefore, the aim of this study was to analyse whether the VP is a safe and suitable method to determine the VO max in patients with HFrEF. Adult male and female patients with HFrEF performed a ramp-incremental phase (IP), followed by a submaximal constant VP (i.e., 95% of the maximal workload during the IP) on a cycle ergometer. A 5-min active recovery period (i.e., 10 W) was performed between the two exercise phases. Group (i.e., median values) and individual comparisons were performed. VO max was confirmed when there was a difference of ≤ 3% in peak oxygen uptake (VO peak) values between the two exercise phases. Twenty-one patients (13 males) were finally included. There were no adverse events during the VP. Group comparisons showed no differences in the absolute and relative VO peak values between both exercise phases ( = 0.557 and = 0.400, respectively). The results did not change when only male or female patients were included. In contrast, individual comparisons showed that the VO max was confirmed in 11 patients (52.4%) and not confirmed in 10 (47.6%). The submaximal VP is a safe and suitable method for the determination of the VO max in patients with HFrEF. In addition, an individual approach should be used because group comparisons could mask individual differences.
验证阶段 (VP) 已被提议作为替代传统标准,用于确定多个人群的最大摄氧量 (VO max)。然而,其在射血分数降低的心力衰竭 (HFrEF) 患者中的有效性仍不清楚。因此,本研究旨在分析 VP 是否是一种安全且合适的方法,用于确定 HFrEF 患者的 VO max。患有 HFrEF 的成年男性和女性患者在自行车测力计上进行递增阶段 (IP),随后进行亚最大恒定 VP (即 IP 期间最大工作负荷的 95%)。在两个运动阶段之间进行 5 分钟的主动恢复期 (即 10 W)。进行了组 (即中位数) 和个体比较。当两次运动阶段之间的峰值摄氧量 (VO peak) 值差异≤ 3%时,即可确认 VO max。最终纳入 21 名患者 (13 名男性)。VP 期间没有发生不良事件。组间比较显示,两个运动阶段的绝对和相对 VO peak 值无差异 ( = 0.557 和 = 0.400,分别)。仅纳入男性或女性患者时,结果并未改变。相比之下,个体比较显示,11 名患者 (52.4%) 的 VO max 得到确认,而 10 名患者 (47.6%) 未得到确认。亚最大 VP 是确定 HFrEF 患者 VO max 的一种安全且合适的方法。此外,应该采用个体方法,因为组间比较可能会掩盖个体差异。